Suppr超能文献

[精神病前期状态——当代诊断与治疗问题。第二部分。精神分裂症风险的生物学标志物。精神病前期状态的治疗]

[Pre-psychotic states--contemporary diagnostic and therapeutic issues. Part II. The biological markers of the risk of schizophrenia. Therapy of pre-psychotic states].

作者信息

Szulc Agata, Czernikiewicz Andrzej

机构信息

Klinika Psychiatrii AM w Białymstoku.

出版信息

Psychiatr Pol. 2007 Jan-Feb;41(1):17-27.

Abstract

The authors review the literature on the topic of early identification and intervention in "pre-psychotic" and "pre-schizophrenic" persons. Most of the early intervention programmes include more or less "false positive results". There is still no classic biological marker of schizophrenia available. Authors review the possible markers of schizophrenia, including some neurophysiological and neurocognitive disorders (eye-tracking dysfunction, sensory motor gating dysfunction, working memory and other neurocognitive dysfunctions) and also structural, neurochemical and functional brain abnormalities. Unfortunately, the marker of transition to psychosis is still unknown. Only the complex analysis of all possible factors: family, social, clinical and biological can be helpful in identification of the future schizophrenic persons. The authors also review the research on the treatment of "pre-psychotic" persons. The most frequent methods used in these cases are the generation antipsychotics in low doses and psychotherapy. The results are promising, but need further confirmation, both in every day practice and in randomized controlled trials.

摘要

作者回顾了关于“精神病前期”和“精神分裂症前期”人群早期识别与干预这一主题的文献。大多数早期干预项目或多或少都包含“假阳性结果”。目前仍没有可用的典型精神分裂症生物学标志物。作者回顾了精神分裂症可能的标志物,包括一些神经生理和神经认知障碍(眼动追踪功能障碍、感觉运动门控功能障碍、工作记忆及其他神经认知功能障碍)以及大脑结构、神经化学和功能异常。不幸的是,向精神病转变的标志物仍然未知。只有对所有可能因素:家庭、社会、临床和生物学因素进行综合分析,才有助于识别未来的精神分裂症患者。作者还回顾了关于“精神病前期”人群治疗的研究。这些病例中最常用的方法是低剂量的新一代抗精神病药物和心理治疗。结果很有前景,但无论是在日常实践还是随机对照试验中都需要进一步证实。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验